Clinical trial
PLUTO: Pediatric Lipid-redUction Trial of rOsuvastatin
NCT00355615 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00355615 |
|---|---|
| Title | PLUTO: Pediatric Lipid-redUction Trial of rOsuvastatin |
| Official title | A Phase IIIb, Efficacy, and Safety Study of Rosuvastatin in Children 10-17 Years of Age With Heterozygous Familial Hypercholesterolemia: a 12-week, Double-blind, Randomized, Multicenter, Placebo-controlled Study With a 40-week, Open-label, Follow-up |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Familial Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | Rosuvastatin, Placebo |
| Enrollment | 173 |
| Start date | Jul 1, 2006 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Jul 24, 2006 |
| Last update posted | Aug 31, 2011 |
| Countries | Canada, Netherlands, Norway, Spain, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: